Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgain AMS on Instagram


  • eChanges December 2021
    Inside this issue AMS News President's Report Congress report Australasian Menopause Society Award – Professor Bronwyn Stuckey Hormone replacement therapy doesn't increase risk of dying early Vale Dr Katie (Catherine) Thorne Seasons Greetings Study Recruiting News from Around t... Read more..
  • eChanges August 2021
    Inside this issue AMS News President's Report A review of online exhibition of women at the heart of general practice Healthed Podcasts Progynova supply shortage and substitute Vale Dr Catherine (Katie) Thorne MBBS (Lond) LRCP MRCS AMS supports action to reduce carbon emissions Midlife a... Read more..
  • eChanges May 2021
    Inside this issue AMS News President's Report Menopause and Midlife Pre appointment Checklist Transdermal patches on PBS  Supply disruptions to Progynova Menopause: The hot topics webinar Healthed Podcasts Midlife and Menopause: Perception in the Pandemic Call for Abstracts - 24th ... Read more..
  • Hormone replacement therapy doesn't increase risk of dying early
    10 December 2021 A large UK study has provided reassurance that taking hormone replacement therapy to relieve menopausal symptoms doesn’t increase the risk of dying early, and may even be slightly protective. Read more..
  • AMS Congress 2021 report
    Adelaide is often referred to as the city shaped by stories. This year at the 24th AMS Congress we added to those stories with our first hybrid conference. The arrival of COVID on our shores necessarily led to changes in how we arranged our programme so for the first time we had both online and ons... Read more..
  • Evaluating the efficacy of Happy Hormones in menopausal women
    The product Happy Hormones is a listed medicine with the Therapeutics Goods Administration (TGA) but it's effectiveness has not been assessed in clinical trials. The AMS supports clinical research to determine the safety and efficacy of all products used in the treatment of menopausal symptoms. A P... Read more..
  • Oestrogen implications with COVID-19
    By Dr Sylvia Rosevear Perhaps at the end of the year we may be saturated with concerns over Covid but here is a brief outline of selected recent publications of observations and emerging data which identify oestrogen and its mechanism of action as a possible ameliorating agent in the treatment... Read more..
  • Common Urinary Issues in Midlife Women
    Dr Amanda L. Clark, an obstetrician-gynecologist and a specialist in urogynecology and menopause in Portland, Oregon. Dr Amanda Clark discusses common midlife urinary and bladder issues and how they can affect a woman’s quality of life Read more..
  • Management of Osteoporosis in Postmenopausal Women: The 2021 Position Statement of NAMS
    Highlights Approximately half of women aged 50 years will experience a fracture related to osteoporosis in their lifetimes, often resulting in significant symptoms and impairment of function and quality of life, but the disorder is substantially underdiagnosed and undertreated. Estrogen de... Read more..
  • Global consensus recommendations on menopause in the workplace
    A European Menopause and Andropause Society (EMAS) position statement Highlights Worldwide, 657 million women are aged 45–59, and around half contribute to the labor force during their menopausal years. The diversity of menopause experience and the effect of menopause on employment are ... Read more..
  • Which Women May Benefit From Statin Therapy?
    Dr Chrisandra Shufelt, NAMS President-Elect; associate director, Barbra Streisand Women’s Health Center and Preventive and Rehabilitative Cardiac Center; director, Women’s Hormone and Menopause Program; and associate professor of medicine at Cedars-Sinai Medical Center in Los Angeles, California. D... Read more..
  • Decreasing the risk of falls and fractures before, during and after menopause
    MAIN POINTS Falls and fractures can happen at any age, but the risk increases as women age. Falls in older people are more likely to cause more severe injuries. Low bone density, low muscle strength and poor balance are more likely as women age and increase the risk of falls. Improving your bo... Read more..
  • The Basics: HT Dose, Route, Formulations
    Dr Gloria Richard-Davis, executive director, Division of Diversity, Equity, and Inclusion, and professor in the Department of Obstetrics and Gynecology at the University of Arkansas for Medical Sciences Dr Richard-Davis discusses considerations when prescribing hormone therapies Read more..
  • MHT & breast cancer
    September 2019:   There is a known association between the use of menopausal hormone therapy (MHT) and breast cancer.  An article by Beral et al for the Collaborative Group on Hormonal Factors in Breast Cancer (Lancet 2019 doi: 10.1016/S0140-6736(19)31709-X) attempts to quantify the ... Read more..
  • A structured approach to menopause consultations
    By Dr Karen Magraith In the May 2021 edition of eChanges, AMS published a ‘Menopause and Midlife Pre-Appointment guide’, prepared by Board Member Dr Meredith Frearson. This guide is designed to help women prepare for a consultation with their health care provider, with links to appropriate sources ... Read more..
  • Sex Differences in COVID-19 Outcomes
    In a study of more than 10,600 adult patients hospitalized with COVID-19, women had significantly lower odds than men of in-hospital mortality. They also had fewer admissions to the intensive care unit and less need for mechanical ventilation. Women also had significantly lower odds of major adverse... Read more..
  • Our Menopause World June 2021
    President’s Report One of our priorities over the past year has been to grow our events and resources for professionals. We have built a strong portfolio that consistently has a high level of engagement, positive feedback and has resulted in increased membership numbers. With the wheels firmly in m... Read more..
  • Addressing Intimate Partner Violence With Midlife Women
    One in four US women and one in ten US men have experienced intimate partner violence (IPV) in their lifetimes, and globally, IPV is the single leading cause of homicide death for women. The prevalence of IPV is highest in women aged 18 to 24 years, but IPV and its consequences also are relevant for... Read more..
  • Position Statement on Improving Bone Health and Osteoporosis Management in Australia
    The Position Statement on Improving Bone Health and Osteoporosis Management in Australia was developed as a result of the Inaugural National Consumer and Community Forum, held on 20 November 2020, and provides specific recommendations and actions to improve the diagnosis and management of ... Read more..
  • Menopause and Midlife Pre-Appointment Guide
    This checklist to assist women planning on seeing a healthcare professional to discuss issues relating to Midlife and Menopause. The first page helps women to find information on the Australasian Menopause Society (AMS) website by explaining how to easily access commonly viewed resources such as th... Read more..

Print Email


Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgainAMS on Instagram